-
1 Comment
Fagron NV is currently in a long term downtrend where the price is trading 7.3% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
Fagron NV's total revenue sank by 0.0% to $140M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $14M since the same quarter in the previous year.
Finally, its free cash flow grew by 105.2% to $29M since the same quarter in the previous year.
Based on the above factors, Fagron NV gets an overall score of 2/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | BE0003874915 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Dividend Yield | 1.6% |
---|---|
Market Cap | 1B |
PE Ratio | 17.25 |
Target Price | None |
Beta | 0.25 |
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders, such as vitiligo; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort; and Cleoderm, a topical cream used for the compounding of personalized dermatological treatments. It also offers education and professional development of prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4A5.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025